The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 201–300 of 910
Statin associated muscle symptoms: An update and review
Dicken, W., Mehta, A., Karagiannis, A. D., Jain, V., Vavuranakis, M., Sperling, L. S., & Cassimatis, D. C. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.010 · Cited by 30
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage
Verdaguer, I. B., Crispim, M., Hernández, A., & Katzin, A. M. (2022) · Molecules · doi:10.3390/molecules27248691 · Cited by 29
Vitamin D status and hypercholesterolemia in Spanish general population
Cutillas‐Marco, E., Prosper, A. F., Grant, W. B., & Morales‐Suárez‐Varela, M. (2013) · Dermato-Endocrinology · doi:10.4161/derm.27497 · Cited by 29
Dunkhunthod, B., Thumanu, K., & Eumkeb, G. (2017) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2017.01.006 · Cited by 29
Oxidative stress as a possible mechanism of statin-induced myopathy
Ahmadi, Y., Ghorbanihaghjo, A., Naghizadeh, M., & Yagin, N. L. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0469-x · Cited by 28
Rodrigues, G., Moreira, A. J., Bona, S., Schemitt, E. G., Marroni, C. A., Naso, F. C. D., Dias, A. S., Pires, T. R., Picada, J. N., & Marroni, N. P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3201873 · Cited by 30
Singh, H., Sharma, A. K., Gupta, M., Singh, A. P., & Kaur, G. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100189 · Cited by 29
Lee, S.-M., & Youn, B. (2020) · Nutrients · doi:10.3390/nu12103058 · Cited by 28
Henne, K. R., Ason, B. L., Howard, M., Wang, W., Sun, J., Higbee, J., Tang, J., Matsuda, K. C., Xu, R., Zhou, L., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221242 · Cited by 28
Gyoten, M., Luo, Y., Fujiwara-Tani, R., Mori, S., Ogata, R., Kishi, S., & Kuniyasu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316814 · Cited by 28
Shivani, Y., Yadav, S., Sasikala, C., & Ramana, C. V. (2016) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001545 · Cited by 27
Ding, Q., Tian, J., Li, M., Lian, F., Zhao, L., Wei, X., Han, L., Zheng, Y., Gao, Z., Yang, H., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.530160 · Cited by 28
Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management
Waiz, M., Alvi, S. S., & Khan, M. S. (2021) · EXCLI journal · doi:10.17179/excli2021-4453 · Cited by 30
Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
Villarruel-Melquiades, F., Mendoza‐Garrido, M. E., García-Cuellar, C. M., Sánchez-Pérez, Y., Pérez‐Carreón, J. I., & Camacho, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i17.2571 · Cited by 27
Okamoto, K., Koda, M., Okamoto, T., Onoyama, T., Miyoshi, K., Kishina, M., Matono, T., Kato, J., Tokunaga, S., Sugihara, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0219412 · Cited by 27
Yamamoto, C., Fukuda, N., Jumabay, M., Saito, K., Matsumoto, T., Ueno, T., Soma, M., Matsumoto, K., & Shimosawa, T. (2010) · Hypertension Research · doi:10.1038/hr.2010.243 · Cited by 27
Mauriello, A., Correra, A., Maratea, A. C., Caturano, A., Liccardo, B., Perrone, M. A., Giordano, A., Nigro, G., D’Andrea, A., & Russo, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051652 · Cited by 29
Process of care for carotid endarterectomy: Perioperative medical management
Stoner, M. C., & deFreitas, D. J. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.10.125 · Cited by 26
Boland, A. J., Gangadharan, N., Kavanagh, P. V., Hemeryck, L., Kieran, J., Barry, M. G., Walsh, P. T., & Lucitt, M. B. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418776261 · Cited by 26
El‐Zahry, M. R., & Ali, M. F. B. (2019) · RSC Advances · doi:10.1039/c8ra10415h · Cited by 26
Sterol synthesis pathway inhibition as a target for cancer treatment
Feltrin, S., Ravera, F., Traversone, N., Ferrando, L., Bedognetti, D., Ballestrero, A., & Zoppoli, G. M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.010 · Cited by 26
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
Belinchón, F. J. Z., Moeller, R. A., Laßwitz, L., van Ham, M., Becker, M., Brogden, G., Rosendal, E., Bi, W., Carriquí-Madroñal, B., Islam, K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103469 · Cited by 25
Su, C., Lu, Y., Wang, Z., Guo, J., Hou, Y., Wang, X., Qin, Z., Gao, J., Sun, Z., Dai, Y., et al. (2022) · Aging and Disease · doi:10.14336/ad.2022.1208 · Cited by 28
Innovations in asthma therapy: is there a role for inhaled statins?
Zeki, A. A., & Elbadawi-Sidhu, M. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1457437 · Cited by 26
Segalin, J., Sirtori, C., Jank, L., Lima, M. F. S., Livotto, P. R., Machado, T. C., Lansarin, M. A., & Pizzolato, T. M. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.05.036 · Cited by 25
Effect of Coenzyme Q10Supplementation in Statin-Treated Obese Rats
Choi, H.-K., Won, E.-K., & Choung, S.-Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.089 · Cited by 24
Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach
Fularski, P., Czarnik, W., Dąbek, B., Lisińska, W., Radzioch, E., Witkowska, A., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105212 · Cited by 26
Alpha lipoic acid and vitamin E improve atorvastatin-induced mitochondrial dysfunctions in rats
Faki, H. E., Traş, B., & Üney, K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.02.011 · Cited by 25
Srisomboon, Y., Squillace, D. L., Maniak, P. J., Kita, H., & O’Grady, S. M. (2020) · The Journal of Physiology · doi:10.1113/jp279379 · Cited by 25
Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion Cascade
Contreras, E. M., Johnston, G. P., Buchholz, D. W., Ortega, V., Monreal, I. A., Zamora, J. L. R., Cheung, T., & Aguilar, H. C. (2021) · Journal of Virology · doi:10.1128/jvi.02323-20 · Cited by 25
Ceja-Galicia, Z. A., Aranda‐Rivera, A. K., Amador‐Martínez, I., Aparicio‐Trejo, O. E., Tapia, E., Trujillo, J., Ramírez, V., & Pedraza‐Chaverrí, J. (2023) · Foods · doi:10.3390/foods12050921 · Cited by 27
Sedki, M., Khalil, I. A. H., & El-sherbiny, I. M. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1505743 · Cited by 26
Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives
Karantas, I. D., Okur, M. E., Okur, N. Ü., & Siafaka, P. I. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200810144004 · Cited by 25
Close, R. M., Close, L. M., Galdun, P., Gerstberger, S. C., Rydberg, M., & Christopher‐Stine, L. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa337 · Cited by 24
Oruganti, L., Sankaran, K. R., Dinnupati, H. G., Kotakadi, V. S., & Meriga, B. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1908366 · Cited by 24
Statins and Male Fertility: Is There a Cause for Concern?
Omolaoye, T. S., Halabi, M., Mubarak, M., Cyril, A. C., Duvuru, R., Radhakrishnan, R., & du Plessis, S. S. (2022) · Toxics · doi:10.3390/toxics10100627 · Cited by 27
Computation-Aided Engineering of Cytochrome P450 for the Production of Pravastatin
Ashworth, M. A., Bombino, E., de Jong, R. M., Wijma, H. J., Janssen, D. B., McLean, K. J., & Munro, A. W. (2022) · ACS Catalysis · doi:10.1021/acscatal.2c03974 · Cited by 24
Development of a Population Pharmacokinetic Model for Atorvastatin Acid and Its Lactone Metabolite
Narwal, R., Akhlaghi, F., Åsberg, A., Hermann, M., & Rosenbaum, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11535980-000000000-00000 · Cited by 24
Sharma, M. S., & Choudhary, P. R. (2014) · PubMed · Cited by 24
Anti-tuberculous Effects of Statin Therapy: A Review of Literature
Tahir, F., Arif, T. B., Ahmed, J., Shah, S. R., & Khalid, M. (2020) · Cureus · doi:10.7759/cureus.7404 · Cited by 24
Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies
Sharata, E. E., Bakry, T., Atta, H. G., Mohammed, H. A., Diab, N. S., Atef, R. A., Hosney, R. S., Omar, M. M., & Hemeida, R. A. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04550-9 · Cited by 31
Dadhich, R., & Kapoor, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00135-0 · Cited by 23
Poledniczek, M., Neumayer, C., Kopp, C. W., Schlager, O., Gremmel, T., Józkowicz, A., Gschwandtner, M. E., Koppensteiner, R., & Wadowski, P. P. (2023) · Biomedicines · doi:10.3390/biomedicines11082284 · Cited by 26
Purohit, A. N., & Ram, H. (2012) · Cited by 22
Targeting prenylation inhibition through the mevalonate pathway
Manaswiyoungkul, P., de Araujo, E. D., & Gunning, P. T. (2019) · RSC Medicinal Chemistry · doi:10.1039/c9md00442d · Cited by 22
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility
Kashour, T., Halwani, R., Arabi, Y. M., Sohail, M. R., O’Horo, J. C., Badley, A. D., & Tleyjeh, I. M. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1863984 · Cited by 22
Park, S., Chang, H. C., & Lee, J. (2021) · Foods · doi:10.3390/foods10071501 · Cited by 23
Moon, J., Lee, S.-Y., Na, H. S., Lee, A. R., Cho, K.-H., Choi, J. W., Park, S., & Cho, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922531 · Cited by 23
Zoungas, S., Curtis, A. J., McNeil, J. J., & Tonkin, A. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.86 · Cited by 22
Silveira, A. A. A., Dominical, V. M., Lazarini, M., Costa, F. F., & Conran, N. (2012) · Inflammation Research · doi:10.1007/s00011-012-0579-7 · Cited by 22
Statins reduce mortality and failure to rescue after carotid artery stenting
Rizwan, M., Faateh, M., Aridi, H. D., Nejim, B. J., Alshwaily, W., & Malas, M. B. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.03.424 · Cited by 22
Antileishmanial effect of mevastatin is due to interference with sterol metabolism
Dinesh, N., Soumya, N., & Singh, S. (2015) · Parasitology Research · doi:10.1007/s00436-015-4618-5 · Cited by 22
Galgóczy, L. (2011) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v1.i1.4 · Cited by 21
Petroglou, D., Kanellos, I., Savopoulos, C. G., Kaiafa, G. D., Chrysochoou, A., Skantzis, P., Daios, S., Hatzitolios, A. I., & Giannoglou, G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180604114819 · Cited by 21
Effect of atorvastatin on testosterone levels
Shawish, M. I., Bagheri, B., Musini, V. M., Adams, S. P., & Wright, J. M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013211.pub2 · Cited by 22
Pel, P., Chae, H., Nhoek, P., Kim, Y., Khiev, P., Kim, G. J., Nam, J., Choi, H., Choi, Y. H., & Chin, Y. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103869 · Cited by 21
Peng, X.-L., Wei-jun, Z., Wang, Y.-S., Dai, K.-L., Cen, Y., Liu, Z., & Zheng, Y. (2020) · 3 Biotech · doi:10.1007/s13205-020-02303-4 · Cited by 23
Lipid-lowering therapies in peripheral artery disease: A review
Skeik, N., Nowariak, M. E., Smith, J. E., Alexander, J. Q., Manunga, J. M., Mirza, A. K., & Sullivan, T. M. (2020) · Vascular Medicine · doi:10.1177/1358863x20957091 · Cited by 21
A phenome-wide association study of genetically mimicked statins
Li, S., & Schooling, C. M. (2021) · BMC Medicine · doi:10.1186/s12916-021-02013-5 · Cited by 20
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria
Matteucci, K. C., Correa, A. A. D. S., & Costa, D. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905278 · Cited by 23
Wang, H., Lichtenstein, A. H., Lamon‐Fava, S., & Jacques, P. F. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.074344 · Cited by 21
Dysfunction of Vascular Smooth Muscle and Vascular Remodeling by Simvastatin
Kang, S., Woo, H.-H., Kim, K., Lim, K., Noh, J.-Y., Lee, M., Bae, Y. M., Bae, O., & Chung, J. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu011 · Cited by 21
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East
Sayed, N., Waili, K. A., Alawadi, F., Al-Ghamdi, S. M. G., Almahmeed, W. A., Alnouri, F., Rukhaimi, M. A., Al‐Rasadi, K., Awan, Z. A., Farghaly, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.081 · Cited by 22
Vemanaradhya, G. G., Emani, S., Mehta, D. S., & Bhandari, S. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.05.022 · Cited by 21
Sarangi, B., Jana, U., Sahoo, J., Mohanta, G. P., & Manna, P. K. (2018) · Biomedical Microdevices · doi:10.1007/s10544-018-0285-5 · Cited by 21
The Application of Statins in the Regeneration of Bone Defects. Systematic Review and Meta-Analysis
Roca-Millan, E., González-Navarro, B., Izquierdo-Gómez, K., Marí-Roig, A., Salas, E. J., López‐López, J., & Velasco‐Ortega, E. (2019) · Materials · doi:10.3390/ma12182992 · Cited by 23
Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Smetana, K. S., Buschur, P. L., Owusu‐Guha, J., & May, C. C. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000299 · Cited by 21
Bartkowiak, A., Matyszewska, D., Krzak, A., Zaborowska, M., Broniatowski, M., & Bilewicz, R. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111784 · Cited by 21
Statins Determination: A Review of Electrochemical Techniques
Antal, I., Koneracká, M., Závišová, V., Kubovčíková, M., Кормош, Ж., & Kopčanský, P. (2017) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2017.1332973 · Cited by 21
Lee, J. G. H., Genga, K. R., Pisitsak, C., Boyd, J. H., Leung, A. K. K., Russell, J. A., & Walley, K. R. (2018) · Critical Care · doi:10.1186/s13054-018-1985-1 · Cited by 20
Raittinen, P. V. H., Syvälä, H., Tammela, T. L. J., Häkkinen, M. R., Ilmonen, P., Auriola, S. O. K., & Murtola, T. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103432 · Cited by 20
Lauridsen, A. R., Skorda, A., Winther, N. I., Bay, M. L., & Kallunki, T. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03172-y · Cited by 23
Statin therapy prevents expansive remodeling in venous bypass grafts
Qiang, B., Toma, J., Fujii, H., Osherov, A. B., Nili, N., Sparkes, J. D., Fefer, P., Samuel, M., BUTANY, J. W., Leong-Poi, H. M., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.013 · Cited by 20
Lee, S., Lee, Y. J., Kim, J., An, J., Kim, K., Lee, H., Kong, H., Song, Y., & Kim, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.101 · Cited by 20
Metabolic enzymes dysregulation in heart failure: the prospective therapy
Parihar, P., & Parihar, M. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9588-x · Cited by 16
Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
Panahi, M., Vadgama, N., Kuganesan, M., Ng, F. S., & Sattler, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110403 · Cited by 20
Mishra, R., Krishan, S., Siddiqui, A. N., Kapur, P., Khayyam, K. U., & Sharma, M. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101902 · Cited by 20
Feldt, M., Menard, J. A., Rosendahl, A. H., Lettiero, B., Bendahl, P., Belting, M., & Borgquist, S. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00231-8 · Cited by 21
Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome.
Pérez‐Castrillón, J. L., Abad, L. H. B., Vega, G., Sanz-Cantalapiedra, A., García-Porrero, M., Pinacho, F., & Dueñas, A. (2008) · PubMed · Cited by 20
Comparison of Minimum Inhibitory Concentration (MIC) value of statin drugs: A Systematic Review
Gupta, M., & Kumar, A. (2018) · Anti-Infective Agents · doi:10.2174/2211352516666180629124433 · Cited by 20
Antioxidant activity of simvastatin prevents L-arginine-induced acute toxicity of pancreas.
Matalka, I. I., Mhaidat, N. M., & Fatlawi, L. A. (2013) · Europe PMC (PubMed Central) · Cited by 20
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence
Kazibwe, R., Rikhi, R. R., Mirzai, S., Ashburn, N. P., Schaich, C. L., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01255-x · Cited by 20
Pallebage‐Gamarallage, M. M., Takechi, R., Lam, V., Elahy, M., & Mamo, J. C. L. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1115820 · Cited by 20
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study
Afzal, A., Fiala, M. A., Gage, B. F., Wildes, T. M., & Sanfilippo, K. M. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.07.003 · Cited by 19
Simvastatin Decreases Sex Hormone Levels in Male Rats
Zhang, X., Li, J., Zhou, X., Guan, Q., Zhao, J., Gao, L., Yu, C., Wang, Y., & Zuo, C. (2016) · Endocrine Practice · doi:10.4158/ep161274.or · Cited by 19
Kim, Y.-S., Han, Y.-E., Choi, E.-A., You, N.-Y., Lee, J., You, H., Kim, Y., Kim, J., & Kang, H. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.08.005 · Cited by 19
Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
Islam, S. M. T., Won, J., Khan, M., Chavin, K. D., & Singh, I. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.11.007 · Cited by 19
Habte, M. L., Seifu, D., Degef, M., Menon, M. K., Yifter, H., & Feyisa, T. O. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s234382 · Cited by 19
Nonalcoholic Fatty Liver Disease.
Ding, L.-L., Oligschlaeger, Y., Shiri-Sverdlov, R., & Houben, T. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_352 · Cited by 4
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19
Zeng, G. J., Lee, M. J. H., Chen, J. Y., Ang, B. F. H., Hao, Y., & Lie, D. T. T. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546520937266 · Cited by 19
Loomba, R. S., & Arora, R. R. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181a2b1a6 · Cited by 19
Assessment of the in vitro and in vivo activity of atorvastatin against Candida albicans.
Ajdidi, A., Sheehan, G., Abu Elteen, K., & Kavanagh, K. (2019) · Journal of medical microbiology · doi:10.1099/jmm.0.001065 · Cited by 18
Varghese, G. K., Abraham, R., Chandran, N. N., & Habtemariam, S. (2017) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-017-0252-5 · Cited by 18
Lipids, lipid-lowering therapy, and neuropathy: a narrative review
Pasha, R., Azmi, S., Ferdousi, M., Kalteniece, A., Bashir, B., Gouni-Berthold, I., Malik, R. A., & Soran, H. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.03.013 · Cited by 18
Metabolite‐derived damage‐associated molecular patterns in immunological diseases
Kang, N., Ji, Z., Li, Y., Gao, J., Wu, X., Zhang, X., Duan, Q., Zhu, C., Xu, Y., Wen, L., et al. (2023) · FEBS Journal · doi:10.1111/febs.16902 · Cited by 20
The pathophysiology and management of depression in cardiac surgery patients
Vu, T., & Smith, J. A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1195028 · Cited by 19
Simakova, M. N., Bisen, S., Dopico, A. M., & Bukiya, A. N. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.022 · Cited by 18
Kao, L., Hung, S., Kao, P., Liu, J., & Lin, H. (2019) · Head & Neck · doi:10.1002/hed.25501 · Cited by 19
Mohammed, Z. I., & Hassan, A. J. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1234/1/012066 · Cited by 18
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review